Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.7, 2003-01, pp. : 501-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M. Jarvis B.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Orlistat in the treatment of Type 2 diabetes mellitus

By Jneidi Muna Kelley David E

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Orlistat gains merit in type 2 diabetes mellitus

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 413, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus

By Simons W. Robert Hagan Michael A.

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 765-780

Adis International

Access to resources Recommend Favorite

Evaluation of the Potential Clinical and Economic Effects of Bodyweight Stabilisation with Acarbose in Patients with Type 2 Diabetes Mellitus: A Decision-Analytical Approach

By Banz K.

PharmacoEconomics, Vol. 13, Iss. 4, 1998-04 ,pp. : 449-459

Adis International

Access to resources Recommend Favorite